Bio


Nicola Calonaci is a postdoctoral scholar at Stanford Cancer Institute, where he develops probabilistic machine-learning methods to study tumour evolution, with a focus on translational oncology. Dr Calonaci holds a PhD in Physics and Chemistry of Biological Systems from SISSA. His research combines cancer omics and Bayesian inference to understand cancer heterogeneity, tumour progression, and treatment response, aiming to generate clinically relevant insights into cancer prognosis and therapeutic strategies.

Stanford Advisors